Absorption of Bioactive Molecules into OASIS Wound Matrix
Authors:
- David A. ZopfDZDavid A. Zopf
- David M.J. ErnstDEDavid M.J. Ernst
- Abram D. JanisAJAbram D. Janis
- Michael C. HilesMHMichael C. Hiles
- Chad JohnsonCJChad Johnson
- 1 October 2007
- journal article
- Published by Wolters Kluwer Health in Advances in Skin & Wound Care
- Vol. 20 (10) , 541-548
Abstract
To examine the ability of OASIS Wound Matrix to absorb, retain, and protect bioactive molecules from solution. Samples of OASIS Wound Matrix were incubated in solutions of bioactive molecules, specifically heparin, albumin, fibronectin, basic fibroblast growth factor 2, and platelet-derived growth factor (PDGF). Half of the samples were then rinsed, and all of the samples were evaluated using enzyme-linked immunosorbent assays (ELISAs) and dye-mediated spectrophotometric methods for absorption and retention of the bioactive molecules. Protection of PDGF was measured by placing PDGF-incubated and control samples into a degradation solution containing plasmin. Intact PDGF levels were then evaluated using a PDGF-specific ELISA. The main outcome measures were the amount of each bioactive molecule that was absorbed after incubation in solutions and retained after rinses as well as the amount of PDGF remaining after plasmin degradation. OASIS Wound Matrix absorbed bioactive molecules from solution, selectively absorbed PDGF from serum, and protected PDGF from protease degradation. Although OASIS Wound Matrix potentially has multiple functions in wound healing, it likely promotes wound healing, in part, by absorbing, retaining, and protecting bioactive molecules from the wound environment.Keywords
This publication has 43 references indexed in Scilit:
- Hyaluronan in human acute and chronic dermal woundsWound Repair and Regeneration, 2006
- Growth factors in the treatment of diabetic foot ulcersBritish Journal of Surgery, 2003
- Decrease of Collagen Deposition in Wound Repair in Type 1 Diabetes Independent of Glycemic ControlArchives of Surgery, 2003
- Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patientsDiabetologia, 2002
- Science, medicine, and the future: Healing chronic woundsBMJ, 2002
- Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcersWound Repair and Regeneration, 2002
- Senescence and the healing rates of venous ulcersJournal of Vascular Surgery, 2001
- Defective Extracellular Matrix Reorganization by Chronic Wound Fibroblasts is Associated with Alterations in TIMP-1, TIMP-2, and MMP-2 ActivityJournal of Investigative Dermatology, 2000
- Fibroblast senescence in pressure ulcersWound Repair and Regeneration, 1998
- Wound Fluids from Human Pressure Ulcers Contain Elevated Matrix Metalloproteinase Levels and Activity Compared to Surgical Wound FluidsJournal of Investigative Dermatology, 1996